Buffalo Translational Consortium News

New CTSA-Funded Pilot Study Investigates the Effectiveness of Storytelling-Based Therapy

Posted on 01/19/16 at 03:21 pm
Is Narrative Exposure Therapy a low-cost solution for treating PTSD and substance abuse among adolescents?

For teenagers from low-income households, trauma from bullying, parental abuse and dating violence often goes untreated since many families can’t afford traditional therapy.

In search of a less-expensive, yet effective, form of therapy, a new study led by UB behavioral health researcher Ellen Volpe will investigate the effectiveness of narrative exposure therapy (NET) in treating post-traumatic stress disorder (PTSD) and substance abuse among adolescents who have experienced multiple traumas. 

The pilot study, “The Effectiveness of Narrative Exposure Therapy (NET) for Diverse Populations Experiencing Multiple Traumas,” is funded by the Mentored Career Development Award from the National Institutes of Health’s Clinical and Translational Science Awards Program.

The full article is available here.


NIH Awards Clinical and Translational Science Award (CTSA) to UB and Partners

Posted on 08/21/15 at 12:41 pm
Timothy Murphy MD, SUNY Distinguished Professor of Medicine, is Principal Investigator of the CTSA.

The NIH has awarded a CTSA to the University at Buffalo and the Buffalo Translational Consortium. This highly competitive grant of $16 million over 4 years will support clinical and translational research throughout the Buffalo Translational Consortium to accelerate the development of new interventions to improve healthcare. The UB Clinical and Translational Research Center serves as the hub of the Buffalo Translational Consortium.

A theme of the CTSA proposal is to bring research to the community. The vision is to perform innovative research across the T1 through T4 translational spectrum to improve health and reduce health disparities in the Buffalo and Western New York community and beyond.

Dr. James Jarvis Advocates for Native American Children

Posted on 08/21/15 at 09:55 am

Dr. James Jarvis, UB Clinical Professor of Pediatrics, has worked tirelessly over the course of his career to improve the health and healthcare of American Indian and Alaska Native children. He uses state-of-the-art methods in his laboratory at the CTRC to study rheumatic disease and the effects of trauma and toxic stress among Native American children.

In his recent testimony before the House Appropriations Subcommittee on the Interior, Environment and Related Agencies, Jarvis supported allocating $5 billion in discretionary authority to the Indian Health Service. The federal agency partners with tribal communities to provide health care for 2.2 million American Indian and Alaska Natives, more than a third of whom are younger than 15. Jarvis spoke on behalf of the American Academy of Pediatrics, as chair of the Committee on Native American Child Health.

Dr. Jarvis played an instrumental role in the signing of an historic agreement between the Indian Health Service and UB Health Sciences Schools in 2013. Through the collaborative agreement, UB is working with tribal leaders to develop and offer public health programs.

The recently funded CTSA grant includes a significant commitment to integrating special populations into the clinical research activities of the Bufffalo Translational Consortium. In particular, it is important to include groups that are underrepresented in clinical research as participants in clinical trials, including children, the elderly and underrepresented minorities. Dr. Jarvis is working as part of the CTSA effort to better engage Native Americans in the Western New York Community in clinical studies.

Buffalo Institute for Genomics (BIG) Gaining Momentum in First Year

Posted on 02/17/15 at 03:24 pm
Machine room in UB Center for Computational Research

Funded by New York State, the Buffalo Institute for Genomics (BIG) is a $110 million collaboration between the University at Buffalo and the New York Genome Center to create a national center for genomics research. Formed in 2014, BIG focuses on personalized medicine to advance the diagnosis and treatment of human disease.

Three UB centers on the Buffalo Niagara Medical Campus are providing high-performance computing, informatics and biomedical expertise as part of this major initiative:

BIG hosted an update on January 22, 2015, at which leaders gave an overview and outlined plans. A key element in the plans is industry partnerships to develop marketable, diagnostic, genomic assays that will guide treatment strategies and drive economic development in the region.

Led by Thomas Furlani PhD, Director CCR, Norma J. Nowak, PhD Executive Director of the CBLS, and Peter Winkelstein MD MBA, Executive Director of the IHI, this unique initiative has the potential to usher in a new era of personalized medicine, leading to breakthrough treatments in serious diseases and improving doctors’ ability to identify individuals at risk of disease.

See here, here and here for more information.

Page 26 of 38